We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+24.71%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
+$149M
(+21%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
7.14%
Holding
453
New
147
Increased
91
Reduced
74
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$4.71M |
| 2 |
GIMO
Gigamon Inc.
GIMO
|
+$4.45M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$4.39M |
| 4 |
SAAS
inContact, Inc.
SAAS
|
+$4.38M |
| 5 |
INN
Summit Hotel Properties
INN
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.11M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$5.46M |
| 3 |
RadNet
RDNT
|
+$5.41M |
| 4 |
PLNR
PLANAR SYSTEMS INC
PLNR
|
+$4.97M |
| 5 |
Motorcar Parts of America
MPAA
|
+$4.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.59% |
| 2 | Technology | 18.66% |
| 3 | Consumer Discretionary | 13.65% |
| 4 | Industrials | 11.89% |
| 5 | Communication Services | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Prothena Corp
PRTA
$444M
| $1.23M | 0.14% |
+32,250
| New | +$827K |
|
|
MSO
277
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
| $1.23M | 0.14% |
188,519
-97,170
| -34% | -$485K |
|
278
Ameris Bancorp
ABCB
$6B
| $1.22M | 0.14% |
46,295
-92,953
| -67% | -$2.35M |
|
|
MFLX
279
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $1.22M | 0.14% |
+66,553
| New | +$1.04M |
|
280
Skywest
SKYW
$4.56B
| $1.21M | 0.14% |
+82,872
| New | +$1.15M |
|
|
HALL
281
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.21M | 0.14% |
11,409
-6,271
| -35% | -$694K |
|
282
Merit Medical Systems
MMSI
$5.12B
| $1.2M | 0.14% |
+62,562
| New | +$1.11M |
|
283
Mercury Systems
MRCY
$6.77B
| $1.2M | 0.14% |
77,000
| – | – |
|
|
WCIC
284
DELISTED
WCI Communities, Inc.
WCIC
| $1.18M | 0.14% |
+49,126
| New | +$1.03M |
|
285
Nathan's Famous
NATH
$402M
| $1.17M | 0.14% |
21,659
+174
| +0.8% | +$13.3K |
|
286
Agree Realty
ADC
$9.49B
| $1.16M | 0.13% |
+35,153
| New | +$1.17M |
|
287
Axcelis
ACLS
$4.29B
| $1.16M | 0.13% |
121,587
+78,137
| +180% | +$808K |
|
288
Alaunos Therapeutics
TCRT
$4.64M
| $1.16M | 0.13% |
+715
| New | +$1.06M |
|
|
CDR
289
DELISTED
Cedar Realty Trust, Inc
CDR
| $1.15M | 0.13% |
+23,310
| New | +$1.17M |
|
290
Great Southern Bancorp
GSBC
$893M
| $1.14M | 0.13% |
28,999
| – | – |
|
291
Paycom
PAYC
$8.17B
| $1.14M | 0.13% |
35,607
-6,570
| -16% | -$195K |
|
|
CBPO
292
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.13M | 0.13% |
11,793
-3,375
| -22% | -$252K |
|
293
CEVA Inc
CEVA
$1.01B
| $1.13M | 0.13% |
+52,751
| New | +$1.03M |
|
294
CareTrust REIT
CTRE
$9.65B
| $1.11M | 0.13% |
+82,110
| New | +$1.06M |
|
|
ITCI
295
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.1M | 0.13% |
+46,132
| New | +$1.03M |
|
|
ARRY
296
DELISTED
Array Biopharma Inc
ARRY
| $1.1M | 0.13% |
+149,121
| New | +$1.06M |
|
297
MarineMax
HZO
$793M
| $1.06M | 0.12% |
39,840
-14,285
| -26% | -$349K |
|
298
PTC Therapeutics
PTCT
$5.77B
| $1.04M | 0.12% |
17,158
-53,715
| -76% | -$3.28M |
|
|
FPRX
299
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.02M | 0.12% |
+44,488
| New | +$1.12M |
|
|
ALDR
300
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.01M | 0.12% |
35,136
-5,195
| -13% | -$143K |
|
Similar funds
RWM
MCM
HP
OMG
RB
ICCFIA
WCM
TSS
EAM Investors's Q1 2015 Portfolio in Review
As of Q1 2015, EAM Investors held 453 positions worth $866M, up 21% from $717M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
EAM Investors deployed $43.9M of net new capital in Q1 2015, opening 147 new positions and adding to 91 existing holdings. Its largest new stake was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Esperion Therapeutics, an estimated $6.11M trimmed.
- EAM Investors's largest Q1 2015 buy was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
- EAM Investors added most to NEVRO CORP. in Q1 2015, an estimated $3.15M increase.
- EAM Investors's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $6.11M.
- EAM Investors fully exited Imperva, Inc. in Q1 2015, selling an estimated $5.46M.
- EAM Investors's ten largest holdings make up 7.1% of its $866M portfolio in Q1 2015.
- EAM Investors opened 147 new positions and closed 130 in Q1 2015.
- EAM Investors's portfolio value rose 21% quarter-over-quarter to $866M.
Based on EAM Investors's 13F filing for Q1 2015, filed 7 May 2015.